{"organizations": [], "uuid": "f466d24a04ccf5914720c5028b44ba00851fee7a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180223.html", "section_title": "Archive News &amp; Video for Friday, 23 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/hypera-results/brazils-hypera-beats-quarterly-profit-estimates-idUSE6N1N200X", "country": "US", "domain_rank": 408, "title": "Brazil's Hypera beats quarterly profit estimates", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-24T06:16:00.000+02:00", "replies_count": 0, "uuid": "f466d24a04ccf5914720c5028b44ba00851fee7a"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/hypera-results/brazils-hypera-beats-quarterly-profit-estimates-idUSE6N1N200X", "ord_in_thread": 0, "title": "Brazil's Hypera beats quarterly profit estimates", "locations": [], "entities": {"persons": [{"name": "marcelo teixeira", "sentiment": "none"}, {"name": "sandra maler", "sentiment": "none"}], "locations": [{"name": "brazil", "sentiment": "none"}, {"name": "hypermarcas", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "hypera sa", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "SAO PAULO, Feb 23 (Reuters) - Brazil’s Hypera SA, the nation’s largest listed producer of over-the-counter medicines, beat fourth quarter profit estimates on Friday.\nIn a securities filing, the drugmaker, which changed its name from Hypermarcas at the beginning of 2018, posted a net income of 462.2 million reais ($142.77 million). That was up 118 percent from a year earlier and above a Reuters consensus estimate of 349 million reais.\nThe company reported Q4 Ebitda of 364.5 million reais, also above Reuters consensus estimate of 281 million reais. ($1 = 3.2374 reais) (Reporting by Marcelo Teixeira; Editing by Sandra Maler)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-24T06:16:00.000+02:00", "crawled": "2018-02-24T13:09:20.018+02:00", "highlightTitle": ""}